← Back to Search

Diagnostic Test

Ultrasound Analysis for Lymphedema

N/A
Waitlist Available
Led By Antonio Forte, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult (18+ years of age)
Has been diagnosed with Lymphedema
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial is testing whether a new ultrasound method can help doctors better understand and treat lymphedema.

Who is the study for?
This trial is for adults over 18 who have been diagnosed with lymphedema and can give written consent. It's not open to those under 18, anyone unable to consent, or patients who've had certain surgeries like lymphovenous bypass or lymph node transfer.Check my eligibility
What is being tested?
The study is testing a new ultrasound technique called SAVE that measures how fluid moves in tissues and helps determine the severity of lymphedema. Researchers want to see if this method is effective for monitoring the condition.See study design
What are the potential side effects?
Since the intervention involves an ultrasound procedure, side effects are minimal but may include temporary discomfort at the site of application or skin irritation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with Lymphedema.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Viscoelasticity parameters with lymphedema as obtained using the SAVE method

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Affected (Lymphedema)Experimental Treatment1 Intervention
Subjects affected lymphedema extremity will have elastic and viscoelastic parameters collected by ultrasound procedure
Group II: Unaffected (Control)Active Control1 Intervention
Subjects unaffected extremity will have elastic and viscoelastic parameters collected by ultrasound procedure

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,694 Total Patients Enrolled
5 Trials studying Lymphedema
503 Patients Enrolled for Lymphedema
Antonio Forte, MDPrincipal InvestigatorMayo Clinic

Media Library

Sub-Hertz Analysis of Viscoelasticity (SAVE) Method (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT04258319 — N/A
Lymphedema Research Study Groups: Unaffected (Control), Affected (Lymphedema)
Lymphedema Clinical Trial 2023: Sub-Hertz Analysis of Viscoelasticity (SAVE) Method Highlights & Side Effects. Trial Name: NCT04258319 — N/A
Sub-Hertz Analysis of Viscoelasticity (SAVE) Method (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04258319 — N/A
Lymphedema Patient Testimony for trial: Trial Name: NCT04258319 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still feasible to enroll participants in this experiment?

"As per clinicaltrials.gov, this trial is no longer accepting applications as the initial posting on July 6th 2020 was last updated on July 12th 2022. Nonetheless, there are 76 other studies recruiting patients at the current moment in time."

Answered by AI

Who else is applying?

What state do they live in?
South Carolina
Mississippi
Wisconsin
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
3+
What site did they apply to?
Mayo Clinic

Why did patients apply to this trial?

I have primary lymphedema (age 50) and so does my daughter (30). Lymphedema in lower extremities and abdomen after cellulitis and hernia repair.
PatientReceived 1 prior treatment
~2 spots leftby Jun 2024